Epstein-Barr virus-induced gene 3 and the p35 subunit of interleukin 12 form a novel heterodimeric hematopoietin
about
IL-35 is a novel responsive anti-inflammatory cytokine--a new system of categorizing anti-inflammatory cytokinesInduction of a novel cellular homolog of interleukin-10, AK155, by transformation of T lymphocytes with herpesvirus saimiriCharged residues dominate a unique interlocking topography in the heterodimeric cytokine interleukin-12Analysis of interleukin-27 (EBI3/p28) expression in Epstein-Barr virus- and human T-cell leukemia virus type 1-associated lymphomas: heterogeneous expression of EBI3 subunit by tumoral cellsBiology of recently discovered cytokines: discerning the pro- and anti-inflammatory properties of interleukin-27A cytokine-centric view of the pathogenesis and treatment of autoimmune arthritisInterleukin-35: Expanding Its Job ProfileInterleukin-27: balancing protective and pathological immunityThe emerging role of Interleukin 27 in inflammatory arthritis and bone destructionBiology of IL-27 and its role in the host immunity against Mycobacterium tuberculosisThe modulation of endoplasmic reticulum stress by chemical chaperone upregulates immune negative cytokine IL-35 in apolipoprotein E-deficient miceOptimized expression and specific activity of IL-12 by directed molecular evolution.Interleukin-35 induces regulatory B cells that suppress autoimmune disease.Role of the TRAF binding site and NF-kappaB activation in Epstein-Barr virus latent membrane protein 1-induced cell gene expressionSignificant reduction of peripheral blood interleukin-35 and CD4+EBI3+ T cells, which are negatively correlated with an increase in the plasma IL-17 and cTnI level, in viral myocarditis patientsThe placental specific gene, PLAC1, is induced by the Epstein-Barr virus and is expressed in human tumor cellsCooperation of multiple signaling pathways in CD40-regulated gene expression in B lymphocytes.Epstein-Barr virus-induced gene 3 (EBI3): a novel diagnosis marker in Burkitt lymphoma and diffuse large B-cell lymphomaThe possible role of the novel cytokines il-35 and il-37 in inflammatory bowel disease.The role of the IL-12 cytokine family in directing T-cell responses in oral candidosis.Interleukin-12: an update on its immunological activities, signaling and regulation of gene expressionDisruption of T helper 2-immune responses in Epstein-Barr virus-induced gene 3-deficient miceDecreased plasma IL-35 levels are related to the left ventricular ejection fraction in coronary artery diseases.IL-35 stimulation of CD39+ regulatory T cells confers protection against collagen II-induced arthritis via the production of IL-10.Increased Th17 and regulatory T cell responses in EBV-induced gene 3-deficient mice lead to marginally enhanced development of autoimmune encephalomyelitis.Tumor-derived IL-35 promotes tumor growth by enhancing myeloid cell accumulation and angiogenesisIL-35-producing B cells are critical regulators of immunity during autoimmune and infectious diseases.A role for IL-27p28 as an antagonist of gp130-mediated signaling.Epstein-Barr virus and rheumatoid arthritis: is there a link?IL-23 and IL-27: new members of the growing family of IL-12-related cytokines with important implications for therapeutics.IL-35 mitigates murine acute graft-versus-host disease with retention of graft-versus-leukemia effectsThe role of cytokines and chemokines in Histoplasma capsulatum infection.Interleukin 35 is an independent prognostic factor and a therapeutic target for nasopharyngeal carcinoma.Inhibiting cytokines of the interleukin-12 family: recent advances and novel challenges.Expression of Epstein-Barr virus-induced gene 3, an interleukin-12 p40-related molecule, throughout human pregnancy: involvement of syncytiotrophoblasts and extravillous trophoblastsEpstein-Barr virus-induced gene 3-deficiency leads to impaired antitumor T-cell responses and accelerated tumor growth.Interleukin 12 (IL-12) family cytokines: Role in immune pathogenesis and treatment of CNS autoimmune disease.Aberrant expression of Treg-associated cytokine IL-35 along with IL-10 and TGF-β in acute myeloid leukemiaInterleukin 35: Critical regulator of immunity and lymphocyte-mediated diseases.New IL-12-family members: IL-23 and IL-27, cytokines with divergent functions.
P2860
Q21090933-99ADE937-8DC5-4194-831A-C4E232885564Q22253378-E66F1116-67AA-44D9-9767-3F5F33960D79Q22254620-1755F54C-59AB-454D-B4E4-F4599DAB9539Q24675683-31C46BFD-BE43-4D22-8F8F-87903DEA5432Q24796992-D42CAB5D-B6B5-4B69-82FB-E71064D04B07Q26823326-DC94AEF2-87DE-4D2F-B6CC-B1EFA9831FFBQ26829619-4103371E-9FBA-4779-B378-738B96AB0090Q26830400-B43F2712-179D-4619-8C56-C589ED6284C1Q26995207-AF330CC1-6001-42DD-A968-D4FAD28266DAQ27014743-DA38F73A-182C-42AB-928E-4E292D2F6E36Q28539349-DC550A9F-4A68-4BC3-891E-27863DAF165FQ33185720-D988CFEF-BEA0-4BE0-B4C2-38A4F5BD5305Q33721777-D3765D67-9090-4A65-B44A-8C1F9C7EA519Q33784729-8B0C1D7E-BEE3-45DE-BE53-7BE59D27237BQ33797114-4A4E43D2-4BDB-40C7-B0EE-107063B0FEA3Q33812158-2524854D-97D4-4C51-90AD-96A50D96FADAQ34009928-A8CA8225-3871-4A74-B84D-68E4897D6FDBQ34023761-E4CCE3D3-5386-49B8-B819-A2678D568799Q34119277-C07CA965-489D-4EE4-BEB0-05E86F76607EQ34235746-800A4A44-E2AE-461F-9350-CBFE461703F2Q34248780-48098204-1E8D-4FB3-BF5F-C689405B0C4FQ34430392-BBEF2BFE-29E8-4126-B774-7BA2E2B93360Q34534000-574C889C-0637-48DA-B022-7F6071E260EEQ34619702-5013BA91-25C0-4199-B3DB-0EA511C49791Q34636409-B1D89C6E-9C21-4F45-B638-7B7205024F0FQ34647584-383AB2A3-B518-453C-8E12-5ECAECB2233EQ34658996-FEFCB0B4-A9AD-419E-A053-CBD83760F6A6Q34688139-898B4BC0-E04C-4ACE-BEB0-8DC69B230C16Q34896078-6511BF78-F7B5-4947-80F4-FB229F20E5EFQ35184704-18795A95-7173-4C41-A97A-9428FD18B896Q35348407-B74C78F0-6FFC-417C-8718-69995E2A1D3DQ35583253-B114E4C3-5D15-446F-A8DF-E6C3C88D2F88Q35648984-0D743341-4F96-4951-994A-683BEC3CC419Q35684429-E3C51A60-15F8-451A-9027-D64AF351291BQ35788425-4AE037AF-95E8-4E37-962A-96934F9561C0Q35799014-C307D639-00C5-42FE-8E33-87E8EC7C5A2DQ36005974-B6FE479F-8E17-4B81-9EC2-EE1277FD0C93Q36075913-D3DD30D1-E98C-4AE3-9F3D-E2BE1C4F11B0Q36090326-690EC5BA-47BD-43F4-8547-261CB11C04A7Q36184396-E9F7C1E6-CDD2-43DE-AF6E-E93674FC00B0
P2860
Epstein-Barr virus-induced gene 3 and the p35 subunit of interleukin 12 form a novel heterodimeric hematopoietin
description
1997 nî lūn-bûn
@nan
1997 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1997 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
1997年の論文
@ja
1997年論文
@yue
1997年論文
@zh-hant
1997年論文
@zh-hk
1997年論文
@zh-mo
1997年論文
@zh-tw
1997年论文
@wuu
name
Epstein-Barr virus-induced gen ...... el heterodimeric hematopoietin
@ast
Epstein-Barr virus-induced gen ...... el heterodimeric hematopoietin
@en
Epstein-Barr virus-induced gen ...... el heterodimeric hematopoietin
@en-gb
Epstein-Barr virus-induced gen ...... el heterodimeric hematopoietin
@nl
type
label
Epstein-Barr virus-induced gen ...... el heterodimeric hematopoietin
@ast
Epstein-Barr virus-induced gen ...... el heterodimeric hematopoietin
@en
Epstein-Barr virus-induced gen ...... el heterodimeric hematopoietin
@en-gb
Epstein-Barr virus-induced gen ...... el heterodimeric hematopoietin
@nl
prefLabel
Epstein-Barr virus-induced gen ...... el heterodimeric hematopoietin
@ast
Epstein-Barr virus-induced gen ...... el heterodimeric hematopoietin
@en
Epstein-Barr virus-induced gen ...... el heterodimeric hematopoietin
@en-gb
Epstein-Barr virus-induced gen ...... el heterodimeric hematopoietin
@nl
P2860
P921
P356
P1476
Epstein-Barr virus-induced gen ...... el heterodimeric hematopoietin
@en
P2093
M Birkenbach
O Devergne
P2860
P304
P356
10.1073/PNAS.94.22.12041
P407
P577
1997-10-28T00:00:00Z